Amrutanjan Health Care Share Price

Amrutanjan Healt

CMP as on 27-May-22 15:30

₹ 785.30
7.85 1.01%

Open

₹ 789.10

Turnover (lac)

₹ 74

Prev. Close

₹ 777.45

Day's Vol (shares)

₹ 9,467

Day's Range (₹)

₹ 781.75
₹ 797.65

CMP as on27-May-22 15:28

₹ 792.90
17.05 2.2%

Open

₹ 803.80

Turnover (lac)

₹ 58

Prev. Close

₹ 775.85

Day's Vol (shares)

₹ 773

Day's Range

₹ 781.90
₹ 803.80

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 17-May-2022 - -
AMRUTANJAN HEALTH CARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2022 inter alia to consider and approve Pursuant to the above mentioned regulation of SEBI LODR we wish to inform that a meeting of the Board of Directors is scheduled to be held on Tuesday the 24th May2022 thru video Conferencing to consider and approve inter-alia (i) Audited Financial Results along with the Audit Report by the statutory Auditors for the quarter and year ended March 3I 2022. (ii)Declaration of Final Dividend for the financial year 2021-22; if any It may also be noted that as already informed vide our letter dt. 30tI March 2022the Trading window for dealing in equity shares of the company is closed effective from 1st April 2022 and will remain closed till 26tr May 2022 pursuant to SEBI (PIT) Regulations 2015 and in terms of Code of Conduct to regulate monitor and report trading in securities of the Company. Request to take the above on record and acknowledge. Amrutanjan Health Care Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 24, 2022, inter alia, has recommended Final Dividend of Rs. 2.60 per equity share on 2,92,30,630 shares of Re. 1 each fully paid up for the financial year 2021-22. The Final dividend if approved at the Annual General Meeting will be paid to eligible shareholders within 30 days of AGM. (As Per BSE Announcement Dated on 24.05.2022)
Board Meeting - 04-Feb-2022 - -
AMRUTANJAN HEALTH CARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2022 inter alia to consider and approve To consider and approve the Unaudited Financial Results for the quarter ended 31/12/2021 AMRUTANJAN HEALTH CARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2022 ,inter alia, to consider and approve Please refer our earlier communication under reference about the Board Meeting. This is to further inform that in the Board Meeting to be held on Friday February 11th 2022 thru Video Conferencing, the Board will also consider declaration of Second Interim Dividend for the year 2021-22 With reference to the earlier letter dated February 04, 2022, about the Board Meeting, Amrutanjan Health Care Ltd has now informed BSE that the Board Meeting to be held on February 11, 2022 thru Video Conferencing, the Board will also consider declaration of Second Interim Dividend for the year 2021-22. (As Per BSE Announcement Dated on 07.02.2022) In terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), we wish to inform that the Board of Directors of the Company at its meeting held today (February 11, 2022) had inter-alia: (i) Approved the Un-audited Financial Results for the quarter ended December 31, 2021. The same along with the Limited Review Report issued by M/s. B S R & Co. LLP, Statutory Auditors of the Company is enclosed. (ii) Declared Second Interim Dividend of Re.1/- per share for the financial year 2021-22 on the Equity Shares of the Company. Amrutanjan Health Care Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 11, 2022, inter alia, have declared Second Interim Dividend of Re.1/- per share for the financial year 2021-22 on the Equity Shares of the Company. Unaudited Financial Results for quarter ended 31/12/2021 (As Per BSE Announcement Dated 11.02.2022)
Board Meeting - 02-Nov-2021 - -
Interim Dividend & Quarterly Results Amrutanjan Health Care Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 09 2021 inter alia has declared First Interim Dividend of Re. 1/- per share for the financial year 2021-22 on the Equity Shares of the Company. In terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), we wish to inform that the Board of Directors of the Company at its meeting held today (November 09, 2021) had inter-alia: (i) Approved the Un-audited Financial Results for the quarter and half year ended September 30, 2021. The same along with the Limited Review Report issued by M/s. B S R & Co. LLP, Statutory Auditors of the Company is enclosed. (ii) Declared First Interim Dividend of Re.1/- per share for the financial year 2021-22 on the Equity Shares of the Company. (As Per BSE Announcement Dated on 11/9/2021 3:55:45 AM)
Board Meeting - 06-Aug-2021 - -
AMRUTANJAN HEALTH CARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2021 inter alia to consider and approve The Un-audited Financial Results for quarter ended June 30 2021 we wish to inform that the Board of Directors of the Company at its meeting held today (August 14, 2021) had inter-alia approved the 1. The Unaudited Financial Results for the quarter ended June 30, 2021 as recommended by the Audit Committee at its meeting held today (August 14, 2021).The same along with the Limited Review Report issued by M/s. B S R & Co. LLP, Statutory Auditors of the Company, is enclosed Re-appointment of Director retiring by rotation (As Per BSE Announcement Dated 14.08.2021)
Board Meeting - 22-Jun-2021 - -
AMRUTANJAN HEALTH CARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/06/2021 ,inter alia, to consider and approve Appointment of Additional Director (Non Executive Independent Catogery) In Compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), we wish to inform that the Board of Directors of the Company at its meeting held today (June 29, 2021) has inter-alia: (i) Approved appointment of Mr. Muralidharan Swayambunathan (DIN: 09198315 ) as an Additional Director (Non-Executive & Independent) of the Company with effect from 29-06-2021to hold office up-to the date of the ensuing Annual General Meeting of the Company. If approved by the shareholders at the AGM, Mr. Muralidharan Swayambunathan will continue as Independent Director on the Board of the Company for a period of five years with effect from 29/06/2021. (As Per BSE Announcement dated on 29.06.2021)
Board Meeting - 13-May-2021 - -
AMRUTANJAN HEALTH CARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2021 ,inter alia, to consider and approve The Audited Financial Results along with the Audit Report by the Statutory Auditors for the quarter and year ended March 31 2021 AMRUTANJAN HEALTH CARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2021 ,inter alia, to consider and approve This is to further inform that in the Board Meeting to be held on Thursday, the 27th May, 2021 thru Video Conferencing, the Board will also consider Declaration of Final Dividend for the year 2020-21 With reference to the earlier letter dated May 13, 2021, about the Board Meeting, Amrutanjan Health Care Ltd has now informed BSE that in the Board Meeting to be held on May 27, 2021, the Board will also consider Declaration of Final Dividend for the year 2020-21. (AS Per BSE Announcement Dated on 18.05.2021) In terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), we wish to inform that the Board of Directors of the Company at its meeting held today (May 27, 2021) has inter-alia: (i) Approved the Audited Financial Results for the quarter and year ended March 31, 2021, as recommended by the Audit Committee at its meeting held today (May 27 2021)The same along with the Independent Auditors Report issued by M/s. B S R & Co. LLP, Statutory Auditors of the Company is enclosed. (ii) Recommended Final Dividend of Rs. 2.60 per equity share on 2,92,30,630 shares of Re. 1 each fully paid up for the financial year 2020-21. The Final dividend if approved at the Annual General Meeting will be paid to eligible shareholders within 30 days of AGM. (iii) Approved appointment of Mr. RAJA VENKATARAMAN (DIN: 00669376) as an Additional Director (Non-Executive & Independent) of the Company with effect from 27-05-2021 (As Per BSE Announcement Dated 27.05.2021) Amrutanjan Health Care Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 27, 2021, inter alia, has recommended Final Dividend of Rs. 2.60 per equity share on 2,92,30,630 shares of Re. 1 each fully paid up for the financial year 2020-21. The Final dividend if approved at the Annual General Meeting will be paid to eligible shareholders within 30 days of AGM. In terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), we wish to inform that the Board of Directors of the Company at its meeting held today (May 27, 2021) has inter-alia: (i) Approved the Audited Financial Results for the quarter and year ended March 31, 2021, as recommended by the Audit Committee at its meeting held today (May 27 2021)The same along with the Independent Auditors Report issued by M/s. B S R & Co. LLP, Statutory Auditors of the Company is enclosed. (ii) Recommended Final Dividend of Rs. 2.60 per equity share on 2,92,30,630 shares of Re. 1 each fully paid up for the financial year 2020-21. The Final dividend if approved at the Annual General Meeting will be paid to eligible shareholders within 30 days of AGM. (iii) Approved appointment of Mr. RAJA VENKATARAMAN (DIN: 00669376) as an Additional Director (Non-Executive & Independent) of the Company with effect from 27-05-2021 In compliance of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirement) Regulation, 2015, we wish to inform you that the Board of Directors, at its Meeting held on 27th May 2021, has: 1) Approved the appointment of Mr Raja Venkataraman (DIN: 00669376) as an Additional Director (Non-Executive, Independent) with effect from 27/05/2021, to hold office up-to the date of the ensuing Annual General Meeting of the Company. If approved by the shareholders at the AGM, Mr. Raja Venkataraman will continue as Independent Director on the Board of the Company for a period of five years with effect from 27/05/2021. (As Per BSE Announcement Dated on 5/27/2021 5:05:27 PM)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity